🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, non-randomized, open-label study will evaluate the effica...
Status
Completed
Location
Western Regional Medical Center at Cancer Treatment Centers of America
Start Date
2014-04-14
Trial ID
NCT02091141
Treatments Being Tested
This clinical trial is looking at a drug called alectinib. Alectinib is app...
Status
Recruiting
Location
Belfast City Hospital
Start Date
2023-12-18
Trial ID
NCT05770037
Treatments Being Tested
This open-label, multicenter study will assess the safety, tolerability, an...
Status
Completed
Location
UC Irvine Medical Center
Start Date
2014-04-03
Trial ID
NCT02013219
Treatments Being Tested
This interventional study aims to determine the pharmacokinetics of orally ...
Status
Recruiting
Location
Thoracic Oncology Unit and Personalized Medicine Laboratory, Instituto Nacional de Cancerología
Start Date
2022-05-01
Trial ID
NCT05713006
Treatments Being Tested
This randomized, active controlled, multicenter phase III open-label study ...
Status
Completed
Location
North Valley Hem Onc Med Grp
Start Date
2014-08-19
Trial ID
NCT02075840
Treatments Being Tested
The objective of N²M² is the improvement of overall survival of patients wi...
Status
Completed
Location
Charité Berlin, Neurosurgery
Start Date
2018-05-07
Trial ID
NCT03158389
Treatments Being Tested
The purpose of this study is to assess the Treatment Strategies and Surviva...
Status
Recruiting
Location
Yongchang Zhang
Start Date
2020-04-16
Trial ID
NCT04322890
Treatments Being Tested
Although many phase III clinical trials evaluate the quality of life as a s...
Status
Recruiting
Location
Fondazione Policlinico Gemelli IRCCS
Start Date
2024-08-05
Trial ID
NCT06532149
A Phase II, open label, non-randomized, multiple-arm, single-center clinica...
Status
Recruiting
Location
Cancer hospital Chinese Academy of Medical Sciences
Start Date
2020-08-15
Trial ID
NCT04423185
The experimental Cohort A (male ALK+ ANSCLC patients receiving alectinib), ...
Status
Completed
Location
Fondazione Policlinico Gemelli IRCCS
Start Date
2018-10-12
Trial ID
NCT06339554
Treatments Being Tested